Clinical Trial

Clinical Investigation to Validate the Safety and Performance of the ABLE Kids Device in Pediatric Patients With Neurological Gait Disorders in a Clinical Setting

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The primary objective of the study is to validate the safety and clinical performance of the ABLE Kids device in pediatric patients with neurological gait disorders or muscular weakness during a 10-session gait training program in a clinical setting. The secondary objective of the study focuses on obtaining preliminary data on the potential clinical and psychosocial benefits of the product.
Trial Details
NCT Number NCT07745712
Lead Sponsor ABLE Human Motion S.L.
Collaborators: Som·hi Rehab
Conditions Gait Impairment, Aquired Brain Injury, Cerebral Palsy (CP), Neuromuscular Diseases (NMD), Spinal Cord Injuries (SCI), Spina Bifida, Muscular Weakness
Enrollment 15 participants
Start Date 2026-09-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-04